6-(2,4-二氯苄基)-1-(4-羟基丁基)-4-氧代-1,4-二氢喹啉-3-羧酸 | 1048998-41-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 6-(2,4-二氯苄基)-1-(4-羟基丁基)-4-氧代-1,4-二氢喹啉-3-羧酸
• 英文名称: 6-(2,4-dichlorobenzyl)-1-(4-hydroxybutyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
• 英文别名: 6-[(2,4-Dichlorophenyl)methyl]-1-(4-hydroxybutyl)-4-oxo-quinoline-3-carboxylic acid；6-[(2,4-dichlorophenyl)methyl]-1-(4-hydroxybutyl)-4-oxoquinoline-3-carboxylic acid
• CAS: 1048998-41-9
• 化学式: C₂₁H₁₉Cl₂NO₄
• 分子量: 420.292
• InChiKey: GNKSISMYHDFYGM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  28
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  77.8
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  ethyl 1-(4-acetoxybutyl)-6-(2,4-dichlorobenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylate 在 sodium hydroxide 、 水 、 盐酸 作用下， 以 水 为溶剂， 反应 2.0h， 以75%的产率得到6-(2,4-二氯苄基)-1-(4-羟基丁基)-4-氧代-1,4-二氢喹啉-3-羧酸
  参考文献：
  名称：

  Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 1. Synthesis and Structure−Activity Relationship of a Class of Human Immunodeficiency Virus type 1 Integrase Inhibitors

  摘要：

  A set of 4-quinolone-3-carboxylic acids bearing different substituents on the condensed benzene ring was designed and synthesized as potential HIV-1 integrase inhibitors structurally related to elvitegravir. Some of the new compounds proved to be able to inhibit the strand transfer step of the virus integration process in the micromolar range. Docking studies and quantum mechanics calculations were used to rationalize these data.

  DOI：

  10.1021/jm8003784

文献信息

• Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 1. Synthesis and Structure−Activity Relationship of a Class of Human Immunodeficiency Virus type 1 Integrase Inhibitors
  作者：Serena Pasquini、Claudia Mugnaini、Cristina Tintori、Maurizio Botta、Alejandro Trejos、Riina K. Arvela、Mats Larhed、Myriam Witvrouw、Martine Michiels、Frauke Christ、Zeger Debyser、Federico Corelli

  DOI：10.1021/jm8003784

  日期：2008.8.1

  A set of 4-quinolone-3-carboxylic acids bearing different substituents on the condensed benzene ring was designed and synthesized as potential HIV-1 integrase inhibitors structurally related to elvitegravir. Some of the new compounds proved to be able to inhibit the strand transfer step of the virus integration process in the micromolar range. Docking studies and quantum mechanics calculations were used to rationalize these data.